IMPLANT SCIENCES CORP
IMX
IMX was delisted on the 3rd of April, 2009.
2 hedge funds and large institutions have $28K invested in IMPLANT SCIENCES CORP in 2015 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
26% less capital invested
Capital invested by funds: $38K → $28K (-$10K)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Regent Investment Management
Louisville,
Kentucky
|
-$7.2K |
| 2 |
CG
Colony Group
Boston,
Massachusetts
|
-$1K |
IMX Hedge Fund Activity: Q2 2015 in Review
2 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in IMPLANT SCIENCES CORP (IMX) for Q2 2015, worth a combined $28K — down 26% from $38K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of IMX and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Regent Investment Management, cutting an estimated $7.2K.
- 2 institutional investors held IMPLANT SCIENCES CORP (IMX) as of Q2 2015, down from 3 in Q1 2015.
- Funds reported $28K of IMPLANT SCIENCES CORP stock for Q2 2015, down 26% quarter-over-quarter.
- 0 funds opened new IMPLANT SCIENCES CORP positions in Q2 2015 and 1 closed out, a net change of -1 holder.
- The largest IMPLANT SCIENCES CORP seller in Q2 2015 was Regent Investment Management, an estimated $7.2K sold.
Based on aggregated 13F filings for Q2 2015.